nivolumab
bms
['melanoma', 'check,mate,76k', 'nivo']
checkmate 76k nivo vs placebo in stage iib/iic melanoma. 790 pts. 1 endpt investigator assessed rfs. presented by . this is the first interim analysis. #smr2022 
Melanoma+Cell Therapy Oncologist @MSKCancerCenter| Cornell/DukeMed/ MGH IM/MSKCC Onc alum | FCOI: https://t.co/kwtet64Pe4